FDA Fast-Tracks Biogen’s Breakthrough Cure for Exceedingly Rare ALS Variant
The US Food and Drug Administration (FDA) has granted accelerated approval to Biogen’s new treatment for a rare form of amyotrophic lateral sclerosis (ALS), allowing patients to access the therapy more quickly. The approval was given to Biogen’s drug Torferson for use in those suffering from the neuromuscular disorder, which is also known as Lou Gehrig’s disease […]